Logos and images
BioThera logos
Vesera™ logos
Vesera™ is a skincare company and BioThera subsidiary.
Science images and people

Transmission electron microscopy (TEM) of BioThera's plant-derived extracellular vesicles before lyophilization. Positively stained vesicles. Scale bar: 500 nm.
Vesicles before lyophilization (TEM)
JPG, 1400 × 1400

TEM of BioThera's plant-derived extracellular vesicles after lyophilization. Positively stained vesicles. Scale bar: 500 nm.
Vesicles after lyophilization (TEM)
JPG, 1400 × 1400

Representative size distribution of BioThera's plant-derived extracellular vesicles, measured by Nanoparticle Tracking Analysis (NTA).
Particle size distribution
PNG, 2000 × 1993

Frédéric St-Denis-Bissonnette, PhD, Founder and CEO.
Founder headshot
JPG
Need a different format, a higher resolution or product photography? Ask the press contact.
Approved wording you can copy
One sentence
BioThera Solutions is an Ottawa-based biotechnology company that manufactures and characterizes extracellular vesicles (EVs, often called exosomes).
Short paragraph
BioThera Solutions is an Ottawa-based biotechnology company building a fully integrated extracellular vesicle (EV, exosome) platform, from research and intellectual property to manufacturing. Every batch is characterized in line with MISEV2023 and documented in its own Certificate of Analysis. For cosmetic applications, BioThera licenses its technology exclusively to Vesera™, a skincare company and BioThera subsidiary. It also supplies research-grade plant-derived EVs to laboratories. Therapeutic applications are research only.
- Legal name
- BioThera Solutions Inc.
- Founded
- 2024
- Headquarters
- Ottawa, Ontario, Canada
- Founder and CEO
- Frédéric St-Denis-Bissonnette, PhD
- What it makes
- Characterized extracellular vesicles (EVs, exosomes); current material is plant-derived, from Aloe barbadensis
- Commercial use today
- Cosmetic applications, through Vesera™, a skincare company and BioThera subsidiary
- Technology status
- Proprietary, patent pending
- Website
- www.biotherasolutions.com
Frédéric St-Denis-Bissonnette, PhD
Frédéric St-Denis-Bissonnette is the Founder and CEO of BioThera Solutions. He holds a PhD with research focused on extracellular vesicle biomanufacturing and characterization, and has authored multiple peer-reviewed first-author publications. He is a named contributor to the MISEV2023 guidelines of the International Society for Extracellular Vesicles and a co-founder of the Canadian Society for Extracellular Vesicles (CanSEV). He received a 2025–2026 Fulbright Canada Short-Term Entrepreneurship Award, with a residency at MIT in April 2026.
Full profile and publicationsColours, typefaces and naming
Blue
#186FA5
Navy
#0D4A73
Teal
#1A9E8A
Black
#0A1628
Typefaces
Cormorant Garamond
Headings
Inter
Body text
Naming and accuracy
- Write "BioThera Solutions" or "BioThera": one word, capital B and T, no hyphen. BioThera Solutions Inc. (Canada) is not affiliated with Bio-Thera Solutions, Ltd. (China).
- Use "extracellular vesicles" or "EVs" as the main term. "Exosomes" is the common market term and can follow in parentheses.
- The technology is "patent pending", not "patented".
- Cosmetic products made with BioThera's material have completed Health Canada's cosmetic notification. A notification is not an approval, so please do not write "approved by Health Canada".
- Vesera™ is a skincare company and a subsidiary of BioThera. BioThera does not sell products to consumers.
- BioThera's work on therapeutic applications is research only. No therapeutic product exists or is offered.
Need something that is not here?
Interviews, fact checks, additional images. Responses go out within one business day.

